1. Effects of aging on urinary tract epithelial homeostasis and immunity
   Marianne M. Ligon et al, 2023, Developmental Biology CrossRef
2. Lymphotoxin β receptor activation promotes mRNA expression of RelA and pro-inflammatory cytokines TNFα and IL-1β in bladder cancer cells
   Mo Shen et al, 2017, Molecular Medicine Reports CrossRef
3. Diagnostic difficulties in cases of papillary urothelial neoplasm of low malignant potential, urothelial proliferation of uncertain malignant potential, urothelial dysplasia and urothelial papilloma: A review of current literature
   Damian Jaworski et al, 2019, Annals of Diagnostic Pathology CrossRef
4. Group 3 innate lymphocytes make a distinct contribution to type 17 immunity in bladder defence
   Alexandra M. Riding et al, 2022, iScience CrossRef
5. NF-κB: Its Role in Pancreatic Cancer
   Appiya Santharam Madanraj et al, 2017, Role of Transcription Factors in Gastrointestinal Malignancies CrossRef
6. Bladder neoplasms and NF-κB: an unfathomed association
   Charles Emmanuel Jebaraj Walter et al, 2020, Expert Review of Molecular Diagnostics CrossRef
7. RelB plays an oncogenic role and conveys chemo-resistance to DLD-1 colon cancer cells
   Xiaojun Zhou et al, 2018, Cancer Cell International CrossRef
8. Post-translational modifications in bladder cancer: Expanding the tumor target repertoire
   Htoo Zarni Oo et al, 2020, Urologic Oncology: Seminars and Original Investigations CrossRef
9. Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
   Andrew Paul et al, 2018, Cells CrossRef
10. Post-Translational Modifications of RelB NF-κB Subunit and Associated Functions
    Véronique Baud et al, 2016, Cells CrossRef
11. Elevated urine histone 4 levels in women with ovarian endometriosis revealed by discovery and parallel reaction monitoring proteomics
    Xin Chen et al, 2019, Journal of Proteomics CrossRef
12. Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways
    Julie Girouard et al, 2020, Biochemical Pharmacology CrossRef
13. Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the “magic bullet” to kill cccDNA
    Ejuan Zhang et al, 2015, Antiviral Research CrossRef